Enzymes - Comprehensive Study Notes (From Transcript)
CHEMISTRY
Introduction
Enzymes are biological catalysts that speed up the rate of biochemical reactions.
Most enzymes are three-dimensional globular proteins (tertiary and quaternary structure).
Some special RNA species act as enzymes and are called ribozymes (e.g., hammerhead ribozyme).
Hammerhead enzyme (image/example referenced).
STRUCTURE OF ENZYMES
The active site is the region that binds substrates, co-factors, and prosthetic groups and contains residues that help hold the substrate.
Active sites generally occupy less than 5% of the total surface area of the enzyme.
Active site has a specific shape due to the protein’s tertiary structure.
A change in the protein’s shape affects the active site shape and thus enzyme function.
ACTIVE SITE
The active site can be divided into:
Binding Site: It chooses the substrate and binds it to the active site.
Catalytic Site: It performs the catalytic action of the enzyme.
CO-FACTORS
Co-factor: a non-protein molecule that enables chemical reactions that cannot be performed by the standard 20 amino acids.
Types:
Organic co-factors
Inorganic cofactors
Without the cofactor attached, the protein is not active. Cofactor binding activates the protein.
INORGANIC CO-FACTORS
These are inorganic molecules required for proper enzyme activity.
Examples:
Carbonic anhydrase requires Zn for activity.
Hexokinase has co-factor Mg.
ORGANIC CO-FACTORS
These are organic molecules required for proper enzyme activity.
Example: glycogen phosphorylase requires the small organic molecule pyridoxal phosphate.
TYPES OF ORGANIC CO-FACTORS
Prosthetic Group: tightly bound organic co-factor (e.g., flavins, heme groups, biotin).
Coenzyme: loosely bound organic co-factor (e.g., NAD+).
Structural representations (e.g., NAD+ with nicotinamide, adenine, ribose components).
TYPES OF CO-FACTORS (CONTINUED)
An enzyme with its co-factor removed is designated as an apoenzyme.
The complete complex of a protein with all necessary small organic molecules, metal ions, and other components is termed a holoenzyme (holoprotein).
Terms:
Apoenzyme
Holoenzyme
SUBSTRATE
The reactant in a biochemical reaction is termed the substrate.
When a substrate binds to an enzyme, it forms an enzyme–substrate complex.
Diagrammatic idea: Substrate joins enzyme to form the complex.
SITES OF ENZYME SYNTHESIS
Enzymes are synthesized by ribosomes attached to the rough endoplasmic reticulum.
Information for enzyme synthesis is carried by DNA.
Amino acids are bonded together to form specific enzymes according to the DNA code.
Ribosomes and endoplasmic reticulum participate in this process.
INTRACELLULAR AND EXTRACELLULAR ENZYMES
Intracellular enzymes: synthesized and retained inside the cell for cellular use.
Found in cytoplasm, nucleus, mitochondria, chloroplasts.
Example: Oxidoreductase catalyzes biological oxidation; some enzymes involved in reduction reside in mitochondria.
Extracellular enzymes: synthesized in the cell but secreted to function outside the cell.
Example: Digestive enzymes produced by the pancreas are transported to the duodenum.
CHARACTERISTICS
Enzymes speed up reactions by lowering activation energy.
Their presence does not affect the nature or properties of the end product.
Enzymes are highly specific; each enzyme catalyzes one kind of substrate.
A small amount of enzyme can accelerate chemical reactions.
Enzymes are sensitive to changes in pH, temperature, and substrate concentration.
Turnover number (Kcat) is the number of substrate molecules transformed per minute by one enzyme molecule.
Example: Catalase turnover number =
NOMENCLATURE OF ENZYMES
An enzyme is named according to the name of the substrate it catalyzes.
Historically, some enzymes were named before systematic naming existed (e.g., pepsin, trypsin, rennin).
By adding the suffix -ase to the substrate name, enzymes are named (e.g., maltose + water → maltase).
Hydrolytic enzymes are termed hydrolases (e.g., maltose + water with maltase).
EXAMPLES
Substrate → Enzyme
lactose → lactase; products: glucose + galactose
maltose → maltase; products: glucose + glucose
cellulose → cellulase; products: glucose
starch → amylase; products: maltose
lipid → lipase; products: glycerol + fatty acids
protein → protease; products: peptides + polypeptide
CLASSIFICATION
A systematic classification of enzymes has been developed by the International Union of Biochemistry and Molecular Biology (IUBMB).
Based on reaction type; six major classes.
Each class is subdivided into sub-classes, sub-sub-classes, etc., to describe numerous enzyme-catalyzed reactions.
CLASSIFICATION OF ENZYMES (CONTINUED)
ENZYME CLASS – REACTION TYPE – EXAMPLES:
Oxidoreductases – Reduction-oxidation (redox) reactions – Example: Lactate dehydrogenase
Transferases – Move chemical groups – Example: Hexokinase
Hydrolases – Hydrolysis; bond cleavage with transfer of functional group of water – Example: Lysozyme
Lyases – Non-hydrolytic bond cleavage – Example: Fumarase
Isomerases – Intramolecular group transfer (isomerization) – Example: Triose phosphate isomerase
Ligases – Synthesis of new covalent bonds using ATP hydrolysis – Example: RNA polymerase
MECHANISM OF ENZYME ACTION
The catalytic efficiency of enzymes is explained from two perspectives:
Thermodynamic changes
Processes at the active site
THERMODYNAMIC CHANGES
All chemical reactions have energy barriers between reactants and products.
The difference between the transition state and substrate is called the activational barrier (activation energy).
Symbols:
Free energy:
Activation barrier for uncatalyzed:
Activation barrier for catalyzed:
Diagrammatic idea: Reactants → Transition state (uncatalyzed) → Products; catalyzed path has a lower transition state energy.
Enzymes provide an alternate pathway for substrate-to-product conversion, lowering the activation energy and increasing the reaction rate.
The total energy of the system remains the same; the equilibrium is not disturbed.
LOCK AND KEY MODEL
Proposed by Emil Fischer in 1894.
The active site is rigid in shape; there is no change in the active site before or after a reaction.
INDUCED FIT MODEL
Proposed by Daniel Koshland in 1958.
Substrate binding causes a conformational change in the enzyme; the active site changes shape to accommodate the substrate and bind effectively.
Induced Fit Hypothesis: binding induces complementary fit between enzyme and substrate.
PHARMACEUTICAL IMPORTANCE
Enzymes are involved in virtually all physiological processes, making them prime targets for drugs.
Applied enzyme kinetics is a principal tool for identifying and characterizing therapeutic agents that selectively inhibit specific enzyme-catalyzed processes.
Enzyme kinetics plays a critical role in drug discovery and in elucidating the mode of action of drugs.
INHIBITION
Inhibition: prevention of an enzyme process due to interaction of inhibitors with the enzyme.
Inhibitors: substances that diminish the velocity of an enzyme-catalyzed reaction.
Inhibition mechanism often involves the inhibitor blocking the active site.
TYPES OF INHIBITION
Reversible Inhibition
Irreversible Inhibition
Competitive
Uncompetitive
Mixed
Non-competitive
REVERSIBLE INHIBITION
Inhibition where the inhibitor can associate and dissociate from the enzyme’s binding site.
TYPES (four):
Competitive inhibition
Uncompetitive inhibition
Mixed inhibition
Non-competitive inhibition
COMPETITIVE INHIBITION
Inhibitors compete with the substrate for the active site.
Formation of E.S complex is reduced while a new E.I complex is formed.
Substrate cannot bind when inhibitor is bound.
EXAMPLES OF COMPETITIVE INHIBITION
Statin drugs (e.g., Lipitor) are competitive inhibitors:
They compete with HMG-CoA for the active site of HMG-CoA reductase, inhibiting cholesterol synthesis.
UNCOMPETITIVE INHIBITION
The inhibitor does not compete with the substrate for the active site.
It binds to a site distinct from the active site (allosteric site).
Forms E.S.I complex with the substrate already bound.
EXAMPLES OF UNCOMPETITIVE INHIBITION
Drugs used to treat methanol or ethylene glycol poisoning act as uncompetitive inhibitors.
Tetramethylene sulfoxide and 3-butylthiolene-1-oxide are uncompetitive inhibitors of liver alcohol dehydrogenase.
MIXED INHIBITION
In this type, both E.I and E.S.I complexes are formed.
Both complexes are catalytically inactive.
NON-COMPETITIVE INHIBITION
A special case of inhibition where the inhibitor has the same affinity for either the free enzyme (E) or the enzyme-substrate complex (E.S).
IRREVERSIBLE INHIBITION
The inhibitor covalently attaches to the enzyme, permanently inactivating it.
Catalytic activity is completely lost and can only be restored by synthesizing new enzyme.
Example: Aspirin covalently modifies a key inflammatory enzyme (irreversible inhibitor).
SUICIDE INHIBITION: a special form where the enzyme converts the inhibitor into a reactive form in its active site.
ACTIVATION
Activation is the conversion of an inactive form of an enzyme to its active form, enabling metabolic activity.
ACTIVATION TYPES
Activation by cofactors.
Conversion of an enzyme precursor (zymogen) to its active form.
ACTIVATION BY CO FACTORS
Many enzymes are activated by cofactors.
Examples:
DNA polymerase is a holoenzyme that catalyzes polymerization of deoxyribonucleotides into a DNA strand; it uses Mg2+ for catalytic activity.
Horse liver dehydrogenase uses Zn2+ for activation.
DIAGNOSTIC SIGNIFICANCES OF ENZYMES
Clinically important enzymes and their concentrations:
Lactate dehydrogenase (LDH) 60-120 IU/L
Transaminases: AST (SGOT) 5-20 IU/L; ALT (SGPT) 5-15 IU/L
Creatine phosphokinase (CPK) 10-60 IU/L
Alkaline phosphatase (ALP) 4-17 King-Armstrong units/100 mL
Acid phosphatase
Isocitrate dehydrogenase
Amylase
Lipase
Concentration increases in: myocardial infarction, myopathy or muscle disorder, leukemias, acute hepatitis, carcinomatosis, liver disorders, pancreatitis, parotitis, obstruction, diabetes, etc.
Gamma-glutamyl transpeptidase (GGT): liver damage indicator (alcoholism).
DIAGNOSTIC SIGNIFICANCES OF ISOENZYMES
Isoenzymes (isoenzymes) are enzyme variants present in specific tissues and elevated under certain conditions.
Examples (LDH isoenzymes):
LDH-1: Heart, red blood cells; elevated in myocardial infarction (MI).
LDH-2: Heart, red blood cells; associated with kidney disease and megaloblastic anemia.
LDH-3: Brain; lung and spleen (tissue distribution varies).
LDH-4: Liver and other tissues; describes situations like urea-related conditions.
LDH-5: Skeletal muscle and liver; associated with muscle diseases and liver disease.
Notes on LDH isoenzyme patterns help in diagnosing specific organ involvement (e.g., MI, liver disease, muscle disorders).
SUMMARY OF KEY EQUATIONS AND NUMBERS
Turnover number (Kcat): the number of substrate molecules transformed per minute by one enzyme molecule.
Example: Catalase turnover number =
Activation energy concepts in thermodynamics: , illustrating the lowered barrier when an enzyme is present.
Enzyme classes (EC numbers follow formal IUBMB classification, six major classes): Oxidoreductases, Transferases, Hydrolases, Lyases, Isomerases, Ligases.
Note: This set of notes mirrors the content provided in the transcript, organized into clear sections with bullets and key examples, including the major models (Lock and Key; Induced Fit), the inhibition types (competitive, uncompetitive, mixed, non-competitive; reversible vs irreversible; examples like statins and aspirin), and diagnostic implications (enzyme levels and LDH isoenzymes).